11 November 2022
ISPOR 2022 Highlights
ECONCARE team presented in person five research posters during ISPOR Europe 2022 on topics related to health economics and outcomes research (HEOR).
ISPOR Europe 2022 is over!
After two years of the covid-19 pandemic period, the conference gave us the opportunity to network in-person with health economics and outcomes research (HEOR) experts and thought leaders, and to discuss with a global audience on how we will establish a more efficient and sustainable health system, sharing value for patients and technology developers.
The ECONCARE team attended this year's conference and presented interesting findings in five posters that you can find below:
The ECONCARE team attended this year's conference and presented interesting findings in five posters that you can find below:
Cost-Effectiveness of Brexucabtagene Autoleucel (Brexu-cel, CAR-T) for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma in Greece (Top 5% Finalist for the ISPOR Europe 2022 Research Presentation Awards ?)
A Budget Impact Analysis of Introducing a New Combination of Atorvastatin and Ezetimibe in Greece